as 03-28-2025 4:00pm EST
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | N/A | IPO Year: | 2006 |
| Target Price: | $16.50 | AVG Volume (30 days): | 596.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.87 - $6.75 | Next Earning Date: | 05-07-2025 |
| Revenue: | $198,772,000 | Revenue Growth: | 3.18% |
| Revenue Growth (this year): | 14.36% | Revenue Growth (next year): | 44.53% |
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Polymeropoulos Mihael Hristos | VNDA | President and CEO | Mar 6 '25 | Buy | $5.02 | 10,000 | $50,150.00 | 2,295,731 | |
| Polymeropoulos Mihael Hristos | VNDA | President and CEO | Mar 5 '25 | Buy | $5.02 | 10,000 | $50,200.00 | 2,295,731 | |
| Polymeropoulos Mihael Hristos | VNDA | President and CEO | Mar 1 '25 | Buy | $4.71 | 10,000 | $47,050.00 | 2,295,731 | |
| Polymeropoulos Mihael Hristos | VNDA | President and CEO | Feb 28 '25 | Buy | $4.76 | 10,000 | $47,600.00 | 2,295,731 | |
| Polymeropoulos Mihael Hristos | VNDA | President and CEO | Feb 27 '25 | Buy | $4.76 | 10,000 | $47,600.00 | 2,295,731 | |
| Polymeropoulos Mihael Hristos | VNDA | President and CEO | Feb 26 '25 | Buy | $4.77 | 10,000 | $47,650.00 | 2,295,731 | |
| Polymeropoulos Mihael Hristos | VNDA | President and CEO | Feb 25 '25 | Buy | $4.46 | 10,000 | $44,640.00 | 2,295,731 | |
| Moran Kevin Patrick | VNDA | SVP, CFO & Treasurer | Feb 21 '25 | Buy | $4.39 | 2,000 | $8,778.80 | 355,763 |
VNDA Breaking Stock News: Dive into VNDA Ticker-Specific Updates for Smart Investing
Argus Research
13 hours ago
Argus Research
2 days ago
Argus Research
3 days ago
Argus Research
4 days ago
Argus Research
5 days ago
Argus Research
8 days ago
Argus Research
9 days ago
Argus Research
10 days ago
The information presented on this page, "VNDA Vanda Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.